1 / 71

Allergy

Allergy. Chapter 20. Immediate hypersensitivity because it begins rapidly, within minutes of antigen challenge ( immediate ), and has major pathologic consequences ( hypersensitivity )

carlberry
Download Presentation

Allergy

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Allergy Chapter 20

  2. Immediate hypersensitivity because it begins rapidly, within minutes of antigen challenge (immediate), and has major pathologic consequences (hypersensitivity) • In clinical medicine, these reactions are called allergy or atopy, and the associated diseases are called allergic, atopic, or immediate hypersensitivity diseases • A variety of human diseases are caused by immune responses to nonmicrobial environmental antigens that involve TH2 cells, immunoglobulin E (IgE), mast cells, and eosinophils • Allergy is the most common disorder of immunity and affects 20% of all individuals in the United States

  3. General Features of Immediate Hypersensitivity Reaction • Hallmarks of allergic diseases are the activation of Th2 cells and the production of IgE antibody • Strong genetic predisposition • Allergens, are usually common environmental proteins and chemicals • Cytokines produced by Th2 cells • Clinical and pathologic manifestations consist of the vascular and smooth muscle reaction that develops rapidly after repeated exposure to the allergen (the immediate reaction) and a delayed late-phase reaction consisting mainly of inflammation

  4. Allergic reactions are manifested in different ways, depending on the tissues affected, including skin rashes, sinus congestion, bronchial constriction, abdominal pain, diarrhea, and systemic shock (Anaphylaxis)

  5. PRODUCTION OF IGE • IgE antibody is responsible for sensitizing mast cells and provides recognition of antigen for immediate hypersensitivity reactions • Atopic individuals produce high levels of IgE in response to environmental allergens, whereas normal individuals generally synthesize other Ig isotypes, such as IgM and IgG, and only small amounts of lgE

  6. The Nature of Allergens • Antigens that elicit immediate hypersensitivity reactions (allergens) are proteins or chemicals bound to proteins to which the atopic individual is chronically exposed • Typical allergens include proteins in pollen, house dust mites, animal dander, foods, and chemicals like the antibiotic penicillin • Two important characteristics of allergens are that individuals are exposed to them repeatedly and, unlike microbes, they do not generally stimulate the innate immune responses that are associated with macrophage and dendritic cell secretion of TH1- and TH17-inducing cytokines • Chronic or repeated T cell activation in the absence of strong innate immunity may drive CD4+ T cells toward the TH2 pathway, as the T cells themselves make IL-4,

  7. These features include low to medium molecular weight (5 to 70 kD), stability, glycosylation, and high solubility in body fluids • Many allergens, such as the cysteine protease of the house dust mite Dermatophagoides pteronyssinus and phospholipase A2 in bee venom, are enzymes, but the importance of the enzymatic activity • Polysaccharidescannot elicit these reactions unless they become attached to proteins, and penicillin react chemically with amino acid residues in self proteins to form hapten-carrier conjugates • Specific IgE antibodies

  8. Aero-allergens

  9. Food allergens

  10. Allergic Reaction

  11. Skin Prick Test (SPT)

  12. THE PROTECTIVE ROLES OF IgE- AND MAST CELL–MEDIATED IMMUNE REACTIONS

  13. Immunotherapy for Allergic Diseases • Several empirical protocols have been developed to diminish specific IgE synthesis called desensitization, small quantities of antigen are repeatedly administered subcutaneously • IgG titers often rise, perhaps further inhibiting IgE production by neutralizing the antigen and by antibody feedback, and induction of Treg to iduce tolerance • Changing the predominant phenotype of antigen-specific T cells from TH2 to TH1 • Other approaches being used to reduce IgE levels include systemic administration of humanized monoclonal anti-IgE antibodies mentioned earlier

  14. Allergic Diseases

  15. Allergic Rhinitis

  16. Allergic Rhinitis : AR is the most common form of perennial rhinitis( % 43 – 77 ) AR is the most common form of allergy ( 500,000,000 )

  17. Risk factors 1 - positive family history of AR 2 – high socio-economic class 3 – total IgE > 100 before 6 year 4 – passive smoking especially before 1 yr 5 – feeding start before 6 month 6 – heavy contact with indoor allergens (esp. mite) 7 – male gender ? 8 – birth in pollination season ? 9 – first baby ( single baby ) ?

  18. AR classification Allergic Rhinitis & & seasonal perennial intermittent persistent

  19. AR classification 1 – seasonal allergic rhinitis ( SAR ) : - often related with outdoor allergens - tree pollens in early spring - grass pollens in spring & summer - weed pollens in summer & autumn 2 – perennial allergic rhinitis ( PAR ) : - often related with indoor allergens - mite , cockroach , danders , mold &…

  20. Inflammatory cells in allergic rhinitis 1 – mast cell 2 – eosinophils 3 – T lymphocyte 4 – dendritic cells & macrophages 5 – epithelial cell

  21. Clinical manifestations : Classic symptoms of allergic rhinitis are : 1 – sneezing 2 – itching ( itchy nose ) 3 – rhinorrhea ( runny nose ) 4 – blockade ( congestion )

  22. Treatment : 1 – Environment control : aeroallergen & food allergen irritants 2 – pharmacotherapy : intermittent ----- anti-H +/- decongestant persistent ------- INCS 3 – Immunotherapy

  23. ASTHMA

  24. Asthma is one of the most common chronic diseases, with an estimated 300 million individuals affected worldwide. Its prevalence is increasing, especially among children • Asthma is a chronicinflammatorydisorderof the airways • Asthma is not a cause for shame. Olympic athletes, famous leaders, other celebrities, and ordinary people live successful lives with asthma

  25. Prevalence data for childhood asthma • Male > female ( prepubertal ) • Female > male ( postpubertal ) • Urban > rural • Developed (western) > undeveloped countries • Slack > white ( minimal different ) • School age > preschool age ( prevalence ) • Preschool age > School age ( incidence )

  26. Allergy & asthma ? % 80 allergic Childhood asthma Adult asthma % 50 allergic

  27. Risk factors for asthma • atopy • allergy to house dust mite • allergen exposure • family history of asthma • early viral RTI • passive smoking • cigarette smoking • maternal smoking • prematurity • male gender • length of breast feeding • food intolerance & hypersensitivity • high dietary intake of sodium • air pollution • urban living

  28. Hygiene – hypothesis

  29. Pathogenesis

  30. Clinical manifestation • The classic symptoms of asthma cough wheez Chest Thightness chest pain

  31. Treatment

  32. Atopic dermatitis (atopic eczema)

  33. Age-specific lesions of AD - in infants cheek , scalp , extensors surface - in older children & adult flexors (politeal fossa, antecubital fossa )

  34. Environment factors 1 – allergens ( aeroallergen – food allergen ) 2 – irritants ( detergent-soaps-low humidity- high humidity-hot air-cold air-,… ) 3 – infections ( S.A , HSV , malsseziafurfur ) 4 – emotional stress 5 – endocrine factors

  35. Vicious cycle of skin infection and AD

  36. Triggers of atopic dermatitis

More Related